InfoBionic is a company focused on enhancing the efficiency and economics of ambulatory remote patient monitoring and cardiac diagnostic services. Founded in 2011, the company has developed the MoMe System, a remote patient monitoring platform initially focused on cardiac arrhythmia detection. Their aim is to improve clinical efficiency and patient care by providing anytime, anywhere access to patient data. The company operates in the AI, Biotechnology, Health Care, and Medical Devices industries, addressing the critical needs of physicians and their patients.
The company recently secured a significant $57.77M Series D investment on 16 October 2023. The investors in this round included Excel Venture Management, Mayo Clinic, Blue Cross Blue Shield Association, and Blue Cross and Blue Shield of Kansas. This latest investment is a testament to the potential and promise InfoBionic holds in the rapidly evolving healthcare technology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series D | $57.77M | 4 |
|
16 Oct 2023 |
| Venture Round | $50.00M | 5 |
|
12 Sep 2018 |
| Private Equity Round | $6.00M | 1 | CB Health Ventures | 01 Jan 2017 |
| Convertible Note | Unknown | 1 |
|
14 Oct 2016 |
| Series B | $8.20M | 3 |
|
23 Jul 2016 |
No recent news or press coverage available for InfoBionic.
We care about your data, and we'd love to use cookies make your experience better.
